logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12064475 B1

PDFFull Text
Date of Patent:
Aug. 20, 2024

Filed:

Feb. 17, 2023

Compositions and method for optimized peptide vaccines using residue optimization

Applicant:

Think Therapeutics, Inc., Newton, MA (US);

Inventors:

David Kenneth Gifford, Newton, MA (US);

Brandon Carter, Cambridge, MA (US);

Assignee:

Think Therapeutics, Inc., Newton, MA (US);

Attorney:

Wilmer Cutler Pickering Hale and Dorr LLP

Primary Examiner:

Thea D' Ambrosio

Int. Cl.
CPC ...
A61K 39/00 (2006.01); A61K 38/00 (2006.01); A61K 38/04 (2006.01); A61K 38/08 (2019.01); A61K 38/10 (2006.01); A61P 35/00 (2006.01); C07K 5/00 (2006.01); C07K 7/00 (2006.01); C07K 7/06 (2006.01); C07K 7/08 (2006.01); C07K 16/00 (2006.01); C07K 17/00 (2006.01); A61K 48/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/00116 (2018.08); A61K 38/08 (2013.01); A61K 38/10 (2013.01); A61K 39/001152 (2018.08); A61K 39/001158 (2018.08); A61P 35/00 (2018.01); C07K 7/06 (2013.01); C07K 7/08 (2013.01); A61K 2039/812 (2018.08); A61K 2039/82 (2018.08); A61K 2039/86 (2018.08); A61K 48/00 (2013.01);
Abstract

Described herein is an immunogenic composition comprising nucleic acid sequences encoding two or more amino acid sequences selected from the group consisting of SEQ ID NOs: 19 to 50. Also described herein is an immunogenic composition comprising nucleic acid sequences encoding two or more amino acid sequences selected from the group consisting of SEQ ID NOs: 141 to 272. Also described herein is an immunogenic composition comprising nucleic acid sequences encoding two or more amino acid sequences selected from the group consisting of SEQ ID NOs: 273 to 322. Also described herein is an immunogenic composition comprising nucleic acid sequences encoding two or more amino acid sequences selected from the group consisting of SEQ ID NOs: 354 to 458.

Find Patent Forward Citations

Loading…